Tiger Brokers

BUZZ-Kura falls after downbeat fourth-quarter results

Reuters
Mar 05
BUZZ-Kura falls after downbeat fourth-quarter results

** Shares of drugmaker Kura Oncology KURA.O fall 5.80% to $8.05 premarket

** Co posts Q4 loss of 92 cents per share, while analysts were expecting a loss of 61 cents per share, according to data compiled by LSEG

** Posts Q4 revenue of $17.3 million, below analysts' estimate of $53.6 million

** R&D expenses for the quarter were $64.4 million, tied to advancement of combination trials for its blood cancer drug, ziftomenib - KURA

** KURA shares had risen over 19% in 2025

(Reporting by Kunal Das in Bengaluru)

((Kunal.Das2@thomsonreuters.com;))

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10